NKGen Biotech, Inc. (NKGN)
NASDAQ: NKGN · Real-Time Price · USD
0.787
+0.144 (22.37%)
At close: Dec 24, 2024, 4:00 PM
0.804
+0.017 (2.21%)
After-hours: Dec 24, 2024, 4:43 PM EST
NKGen Biotech Market Cap
NKGen Biotech has a market cap or net worth of $28.33 million as of December 24, 2024. Its market cap has decreased by -61.93% in one year.
Market Cap
28.33M
Enterprise Value
55.75M
1-Year Change
-61.93%
Ranking
Category
Stock Price
$0.79
Market Cap Chart
Since August 4, 2023, NKGen Biotech's market cap has decreased from $338.09M to $28.33M, a decrease of -91.62%. That is a compound annual growth rate of -83.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2024 | 23.15M | -61.54% |
| Dec 29, 2023 | 60.19M | -82.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HOOKIPA Pharma | 24.47M |
| AEON Biopharma | 23.96M |
| DarioHealth | 23.78M |
| Akari Therapeutics, | 23.52M |
| Co-Diagnostics | 23.28M |
| Gelteq | 22.93M |
| NeuroOne Medical Technologies | 22.88M |
| BioLineRx | 22.71M |